258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial. (12th April 2019)

Record Type:: Journal Article
Title:: 258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial. (12th April 2019)
Main Title:: 258 Secukinumab provides sustained improvements in the signs and symptoms in psoriatic arthritis: final 5-year efficacy and safety results from the FUTURE 1 Phase 3 trial
Authors:: Tahir, Hasan
Mease, Philip J
Kavanaugh, Arthur
Reimold, Andreas
Rech, Jürgen
Hall, Stephen
Geusens, Piet
Pellet, Pascale
Delicha, Eumorphia Maria
Pricop, Luminita
Mpofu, Shephard
Abstract:
Is Part Of:: Rheumatology. Volume 58(2019)Supplement 3
Journal:: Rheumatology
Issue:: Volume 58(2019)Supplement 3
Issue Display:: Volume 58, Issue 3 (2019)
Year:: 2019
Volume:: 58
Issue:: 3
Issue Sort Value:: 2019-0058-0003-0000
Page Start:
Page End:
Publication Date:: 2019-04-12
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/kez107.074 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12102.xml